Company Overview - Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule precision medicines for kidney and metabolic diseases, including obesity [3] - The company utilizes its Compass™ platform to pursue genetically validated targets, integrating variant discovery and functionalization to advance small molecule programs with first- or best-in-class potential [3] Pipeline Development - Maze's leading pipeline candidates include MZE829, a dual-mechanism APOL1 inhibitor currently in Phase 2 development for APOL1-mediated kidney disease (AMKD) [3] - Another candidate, MZE782, is a SLC6A19 inhibitor advancing to Phase 2, with potential applications in treating both phenylketonuria (PKU) and chronic kidney disease (CKD) [3] Upcoming Events - Jason Coloma, Ph.D., the CEO of Maze Therapeutics, is scheduled to present at the TD Cowen 46 Annual Health Care Conference on March 4, 2026, at 10:30 a.m. ET [1] - A live webcast of the presentation will be available on the company's website and archived for 60 days [2]

Core Insights - Maze Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecule precision medicines for kidney and metabolic diseases, including obesity [2] - The company will participate in four upcoming investor conferences, providing live webcasts and archived presentations [1][3] Company Overview - Maze Therapeutics utilizes human genetics to create novel small molecule precision medicines, guided by its Compass™ platform [2] - The company's leading pipeline products include MZE829, a dual-mechanism APOL1 inhibitor in Phase 2 for APOL1-mediated kidney disease, and MZE782, a SLC6A19 inhibitor advancing to Phase 2 for phenylketonuria and chronic kidney disease [2] Upcoming Events - The company will engage in the following investor conferences: - Guggenheim 2nd Annual Healthcare Innovation Conference on November 11, 2025, at 9:30 a.m. ET [3] - TD Cowen Immunology & Inflammation Summit on November 13, 2025, at 2:00 p.m. ET [3] - Jefferies Global Healthcare Conference in London on November 20, 2025, at 12:00 p.m. GMT / 7:00 a.m. ET [3] - 8th Annual Evercore Healthcare Conference on December 3, 2025, at 10:25 a.m. ET [3]